参考文献/References:
[1]童武松,王松林,潘金华.顺铂联合紫杉醇同步放化疗对中晚期宫颈癌患者免疫功能及血清CY-FRA21-1、SCC-Ag的影响[J].海南医学院学报,2016,22(23):2866-2868.[2]王芳芳,廖思辉,陈运强,等.不同化疗药物联合同期放疗治疗局部中晚期宫颈癌的临床疗效及不良反应观察[J].广西医科大学学报,2019,36(3):412-415.[3]Hakim A,Ghoshal S,Verma R,et al.Comparison of Functional Organ Preservation by Concomitant Boost Radiotherapy Versus Concurrent Chemoradiation in Locally Advanced Carcinoma of Larynx or Hypopharynx:A Prospective Randomized Study[J].Indian J Otolaryngol Head Neck Surg,2019,71(3):360-366.[4]张萍,艾斌.实体瘤免疫治疗疗效评价标准[J].国际肿瘤学杂志,2016,43(11):848-851.[5]赵肖丽,周伟慢,王华,等.伊立替康联合顺铂同步放化疗治疗晚期宫颈癌的临床价值及毒副反应分析[J].解放军医药杂志,2019,31(8):30-33.
相似文献/References:
[1]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2019,32(24):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[2]刘 贝,郑 慧,周 旺,等.3D-STI联合心脏综合指数评价肺癌患者GP化疗方案的隐匿性心肌毒性[J].医学信息,2019,32(08):100.[doi:10.3969/j.issn.1006-1959.2019.08.029]
LIU Bei,ZHENG Hui,ZHOU Wang,et al.Evaluation of Occult Myocardial Toxicity in GP Chemotherapy Regimen of Lung Cancer Patients by 3D-STI Combined with Cardiac Comprehensive Index[J].Medical Information,2019,32(24):100.[doi:10.3969/j.issn.1006-1959.2019.08.029]
[3]张秀芳,陈 萍.安罗替尼联合顺铂治疗晚期卵巢癌恶性腹腔积液的疗效观察[J].医学信息,2019,32(18):132.[doi:10.3969/j.issn.1006-1959.2019.18.044]
ZHANG Xiu-fang,CHEN Ping.Efficacy of Erlotinib Combined with Cisplatin in the Treatment of Advanced Ovarian Cancer with Malignant Ascites[J].Medical Information,2019,32(24):132.[doi:10.3969/j.issn.1006-1959.2019.18.044]
[4]任勇军,闵旭立,徐 浩,等.洛铂联合表柔比星化疗栓塞治疗原发性肝细胞癌的疗效[J].医学信息,2019,32(24):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]
REN Yong-jun,MIN Xu-li,XU Hao,et al.Efficacy of Loplatin Combined with Epirubicin Chemotherapy and Embolization for Primary Hepatocellular Carcinoma[J].Medical Information,2019,32(24):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]
[5]李 博.紫杉醇加顺铂治疗晚期老年非小细胞癌的疗效[J].医学信息,2020,33(10):153.[doi:10.3969/j.issn.1006-1959.2020.10.045]
LI Bo.Paclitaxel Plus Cisplatin in the Treatment of Advanced Elderly Non-small Cell Carcinoma[J].Medical Information,2020,33(24):153.[doi:10.3969/j.issn.1006-1959.2020.10.045]
[6]文 龙,张 彬.食管癌的治疗现状及趋势分析[J].医学信息,2022,35(18):165.[doi:10.3969/j.issn.1006-1959.2022.18.046]
WEN Long,ZHANG Bin.Treatment Status and Trend Analysis of Esophageal Cancer[J].Medical Information,2022,35(24):165.[doi:10.3969/j.issn.1006-1959.2022.18.046]
[7]王宇鹏,杜学明.上腔静脉压迫综合征的放化疗治疗[J].医学信息,2022,35(21):163.[doi:10.3969/j.issn.1006-1959.2022.21.044]
WANG Yu-peng,DU Xue-ming.Chemoradiotherapy for Superior Vena Cava Compression Syndrome[J].Medical Information,2022,35(24):163.[doi:10.3969/j.issn.1006-1959.2022.21.044]
[8]苏 凝,樊利萍,秦丽丽,等.恩度联合顺铂胸腔内灌注治疗非小细胞肺癌恶性胸腔积液的疗效[J].医学信息,2021,34(11):155.[doi:10.3969/j.issn.1006-1959.2021.11.043]
SU Ning,FAN Li-ping,QIN Li-li,et al.Efficacy of Endu Combined with Cisplatin Intrapleural Perfusion in the Treatment of Non-small Cell Lung Cancer with Malignant Pleural Effusion[J].Medical Information,2021,34(24):155.[doi:10.3969/j.issn.1006-1959.2021.11.043]
[9]何显阳,刘方文,黄云英,等.多西他赛联合顺铂新辅助化疗对非小细胞肺癌治疗中相关肿瘤标记物的影响[J].医学信息,2021,34(23):165.[doi:10.3969/j.issn.1006-1959.2021.23.050]
HE Xian-yang,LIU Fang-wen,HUANG Yun-ying,et al.Effect of Docetaxel Combined with Cisplatin Neoadjuvant Chemotherapy on Related Tumor Markers in the Treatment of Non-small Cell Lung Cancer[J].Medical Information,2021,34(24):165.[doi:10.3969/j.issn.1006-1959.2021.23.050]
[10]张书林,黄盛源,刘忠林,等.吉西他滨和多西他赛联合顺铂治疗晚期非小细胞肺鳞癌的效果比较[J].医学信息,2021,34(24):141.[doi:10.3969/j.issn.1006-1959.2021.24.036]
ZHANG Shu-lin,HUANG Sheng-yuan,LIU Zhong-lin,et al.Comparison of Gemcitabine and Docetaxel Combined with Cisplatin in the Treatment of Advanced Non-small Cell Lung Squamous Cell Carcinoma[J].Medical Information,2021,34(24):141.[doi:10.3969/j.issn.1006-1959.2021.24.036]